{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:01:45Z","timestamp":1790499705233,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The conjunctiva is a mucous membrane that covers the sclera and lines the inside of the eyelids. Throughout the conjunctiva are goblet cells that secrete mucins to protect the eye. Chronic inflammatory diseases such as allergic conjunctivitis and early dry eye lead to increased goblet cell mucin secretion into tears and ocular surface disease. The purpose of this study was to determine the actions of the inflammatory mediators, the leukotrienes and the proresolution resolvins, on secretion from cultured rat and human conjunctival goblet cells. We found that both cysteinyl leukotriene (CysLT) receptors, CysLT1 and CysLT2, were present in rat conjunctiva and in rat and human cultured conjunctival goblet cells. All leukotrienes LTB4, LTC4, LTD4, and LTE4, as well as PGD2, stimulated goblet cell secretion in rat goblet cells. LTD4 and LTE4 increased the intracellular Ca2+ concentration ([Ca2+]i), and LTD4 activated ERK1\/2. The CysLT1 receptor antagonist MK571 significantly decreased LTD4-stimulated rat goblet cell secretion and the increase in [Ca2+]i. Resolvins D1 (RvD1) and E1 (RvE1) completely reduced LTD4-stimulated goblet cell secretion in cultured rat goblet cells. LTD4-induced secretion from human goblet cells was blocked by RvD1. RvD1 and RvE1 prevented LTD4- and LTE4-stimulated increases in [Ca2+]i, as well as LTD4 activation of ERK1\/2. We conclude that cysteinyl leukotrienes stimulate conjunctival goblet cell mucous secretion with LTD4 using the CysLT1 receptor. Stimulated secretion is terminated by preventing the increase in [Ca2+]i and activation of ERK1\/2 by RvD1 and RvE1.<\/jats:p>","DOI":"10.4049\/jimmunol.1000833","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T16:11:07Z","timestamp":1298995867000},"page":"4455-4466","source":"Crossref","is-referenced-by-count":101,"title":["Conjunctival Goblet Cell Secretion Stimulated by Leukotrienes Is Reduced by Resolvins D1 and E1 To Promote Resolution of Inflammation"],"prefix":"10.1093","volume":"186","author":[{"given":"Darlene A","family":"Dartt","sequence":"first","affiliation":[{"name":"Schepens Eye Research Institute, Harvard Medical School , Boston, MA 02114"},{"name":"Department of Ophthalmology, Harvard Medical School , Boston, MA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin R","family":"Hodges","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute, Harvard Medical School , Boston, MA 02114"},{"name":"Department of Ophthalmology, Harvard Medical School , Boston, MA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayu","family":"Li","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute, Harvard Medical School , Boston, MA 02114"},{"name":"Department of Ophthalmology, Harvard Medical School , Boston, MA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A","family":"Shatos","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute, Harvard Medical School , Boston, MA 02114"},{"name":"Department of Ophthalmology, Harvard Medical School , Boston, MA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameran","family":"Lashkari","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute, Harvard Medical School , Boston, MA 02114"},{"name":"Department of Ophthalmology, Harvard Medical School , Boston, MA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N","family":"Serhan","sequence":"additional","affiliation":[{"name":"Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA 02115"},{"name":"Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"2025032411180359200_r1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(02)00083-3","article-title":"The airway goblet cell","volume":"35","author":"Rogers","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2025032411180359200_r2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archotol.130.6.747","article-title":"Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis","volume":"130","author":"Kim","year":"2004","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"2025032411180359200_r3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diff.2008.09.008","article-title":"Differences in goblet cell differentiation between Crohn\u2019s disease and ulcerative colitis","volume":"77","author":"Gersemann","year":"2009","journal-title":"Differentiation"},{"key":"2025032411180359200_r4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul. Surf."},{"key":"2025032411180359200_r5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.exer.2003.10.005","article-title":"Control of mucin production by ocular surface epithelial cells","volume":"78","author":"Dartt","year":"2004","journal-title":"Exp. Eye Res."},{"key":"2025032411180359200_r6","first-page":"2127","article-title":"Development of conjunctival goblet cells and their neuroreceptor subtype expression","volume":"41","author":"R\u00edos","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r7","first-page":"1102","article-title":"Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion","volume":"40","author":"R\u00edos","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/exer.2000.0915","article-title":"Regulation of conjunctival goblet cell secretion by Ca(2+)and protein kinase C. [Published erratum appears in 2001 Exp. Eye Res. 72 :357.]","volume":"71","author":"Dartt","year":"2000","journal-title":"Exp. Eye Res."},{"key":"2025032411180359200_r9","doi-asserted-by":"crossref","first-page":"C988","DOI":"10.1152\/ajpcell.00582.2001","article-title":"Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion","volume":"284","author":"Kanno","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2025032411180359200_r10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"key":"2025032411180359200_r11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411180359200_r12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411180359200_r13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025032411180359200_r14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.plefa.2008.09.012","article-title":"Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators","volume":"79","author":"Serhan","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"2025032411180359200_r15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni.1627","article-title":"Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation","volume":"9","author":"Haworth","year":"2008","journal-title":"Nat. Immunol."},{"key":"2025032411180359200_r16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025032411180359200_r17","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.4049\/jimmunol.181.12.8677","article-title":"Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution","volume":"181","author":"Kasuga","year":"2008","journal-title":"J. Immunol."},{"key":"2025032411180359200_r18","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury","volume":"177","author":"Duffield","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411180359200_r19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Med."},{"key":"2025032411180359200_r20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/0192623309351724","article-title":"Corneal neovascularization and ocular irritancy responses in dogs following topical ocular administration of an EP4-prostaglandin E2 agonist","volume":"37","author":"Aguirre","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"2025032411180359200_r21","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1167\/iovs.08-1677","article-title":"ERK\/p44p42 mitogen-activated protein kinase mediates EGF-stimulated proliferation of conjunctival goblet cells in culture","volume":"49","author":"Shatos","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r22","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1167\/iovs.08-2930","article-title":"Stimulatory role of PKCalpha in extracellular regulated kinase 1\/2 pathway in conjunctival goblet cell proliferation","volume":"50","author":"Shatos","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r23","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1167\/iovs.02-0550","article-title":"Isolation and characterization of cultured human conjunctival goblet cells","volume":"44","author":"Shatos","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025032411180359200_r25","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2025032411180359200_r26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1167\/iovs.06-1226","article-title":"Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation","volume":"48","author":"R\u00edos","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-3565(25)10418-7","article-title":"A second cysteinyl leukotriene receptor in human lung","volume":"263","author":"Labat","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025032411180359200_r28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1432-1033.1993.tb18012.x","article-title":"5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase","volume":"215","author":"Abramovitz","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"2025032411180359200_r29","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci U S A"},{"key":"2025032411180359200_r30","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025032411180359200_r31","doi-asserted-by":"crossref","first-page":"9956","DOI":"10.1074\/jbc.M313016200","article-title":"The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency","volume":"279","author":"Wittamer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2025032411180359200_r32","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1365-2222.2007.02782.x","article-title":"Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo","volume":"37","author":"Galatowicz","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"2025032411180359200_r33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.all.0000244801.79475.66","article-title":"Pharmacology of ocular allergy","volume":"6","author":"Schultz","year":"2006","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"2025032411180359200_r34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"2025032411180359200_r35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Smith","year":"2007","journal-title":"Ocul. Surf."},{"key":"2025032411180359200_r36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025032411180359200_r37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(89)90628-6","article-title":"Platelet-activating factor causes goblet cell depletion in the conjunctiva","volume":"168","author":"Woodward","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"2025032411180359200_r38","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1167\/iovs.02-1117","article-title":"Activation of mitogen-activated protein kinase by cholinergic agonists and EGF in human compared with rat cultured conjunctival goblet cells","volume":"44","author":"Horikawa","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.121.5.615","article-title":"Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma","volume":"121","author":"Lambiase","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"2025032411180359200_r40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"2025032411180359200_r41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2003.12.012","article-title":"Molecular and functional aspects of human cysteinyl leukotriene receptors","volume":"50","author":"Capra","year":"2004","journal-title":"Pharmacol. Res."},{"key":"2025032411180359200_r42","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"J. Exp. Med."},{"key":"2025032411180359200_r43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2008.01.012","article-title":"Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma","volume":"367","author":"Aoki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025032411180359200_r44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jn\/132.1.11","article-title":"Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis","volume":"132","author":"Nieto","year":"2002","journal-title":"J. Nutr."},{"key":"2025032411180359200_r45","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1167\/iovs.08-2462","article-title":"Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators","volume":"50","author":"Jin","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2025032411180359200_r46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/bjp.2008.367","article-title":"An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption","volume":"155","author":"Herrera","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"2025032411180359200_r47","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411180359200_r48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1096\/fj.05-4724fje","article-title":"RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis","volume":"20","author":"Hasturk","year":"2006","journal-title":"FASEB J."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/186\/7\/4455\/62469341\/1000833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/186\/7\/4455\/62469341\/1000833.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:55:56Z","timestamp":1743155756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/186\/7\/4455\/7990245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1000833","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13284958.14644056","asserted-by":"object"}]},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,4]]},"published":{"date-parts":[[2011,4,1]]}}}